Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaxanib + 5-FU/Leucovorin in Metastatic Colorectal Cancer
NCT00004252Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 1999
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of semaxanib in metastatic colorectal cancer (mCRC), sponsored by Pfizer. Started Nov 1999; status: completed.
02
Drugs
semaxanib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00004252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004252.